Allianz Asset Management Gmb H Bio Rad Laboratories, Inc. Transaction History
Allianz Asset Management Gmb H
- $74.9 Billion
- Q2 2025
A detailed history of Allianz Asset Management Gmb H transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 54,239 shares of BIO stock, worth $16.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
54,239
Previous 16,346
231.82%
Holding current value
$16.9 Million
Previous $3.98 Million
228.76%
% of portfolio
0.02%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding BIO
# of Institutions
426Shares Held
19.2MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$786 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$577 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$484 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$312 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$270 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.7B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...